A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy

• Status: Unknown status
• Trial end date: 2019-03-31
• Target enrollment: 0
• Participant gender: Female

Summary

The investigators aim to determine if Vitamin D prophylaxis in pregnancy reduces the incidence of hypertensive disorders of pregnancy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Stony Brook University
• Treatments: Cholecalciferol; Ergocalciferols; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• 18 years of age and older

• With a confirmed intrauterine pregnancy, less than 16 weeks gestation

• Carrying a singleton gestation

Exclusion Criteria:

• Taking Vitamin D supplementation outside of prenatal vitamins

• Has a known disorder that will affect vitamin D levels (i.e, hyperparathyroidism, mal-absorption disorder, history of gastric bypass surgery, immunocompromised state, maternal use of immune-modulators etc.)

• Carrying a fetus with known aneuploidy or anomaly

• With fetal demise

• Women with chronic diuretic or cardiac medication therapy including calcium channel blockers